ENHABIT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.72 USD | -1.25% |
|
-0.34% | -15.75% |
| Jul. 05 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| Jul. 05 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 653 | 518.8 | 442.9 | - | - |
| Enterprise Value (EV) 1 | 1,213 | 1,044 | 959.6 | 935.2 | 931.1 |
| P/E ratio | 10.4 x | -6.43 x | 48 x | 29.8 x | 30.4 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 0.6 x | 0.5 x | 0.41 x | 0.39 x | 0.37 x |
| EV / Revenue | 1.12 x | 1 x | 0.89 x | 0.83 x | 0.79 x |
| EV / EBITDA | 7.62 x | 10.7 x | 9.42 x | 8.68 x | 7.98 x |
| EV / FCF | 16.6 x | 23.3 x | 24.6 x | 20.5 x | - |
| FCF Yield | 6.02% | 4.3% | 4.06% | 4.89% | - |
| Price to Book | 0.77 x | 0.77 x | 0.65 x | 0.63 x | 0.61 x |
| Nbr of stocks (in thousands) | 49,618 | 50,130 | 50,156 | - | - |
| Reference price 2 | 13.16 | 10.35 | 8.830 | 8.830 | 8.830 |
| Announcement Date | 2/15/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,083 | 1,046 | 1,076 | 1,123 | 1,184 |
| EBITDA 1 | - | 159.3 | 97.6 | 101.9 | 107.7 | 116.6 |
| EBIT 1 | - | 107.6 | 66.7 | 65.85 | 72.69 | 81.81 |
| Operating Margin | - | 9.93% | 6.37% | 6.12% | 6.47% | 6.91% |
| Earnings before Tax (EBT) 1 | - | 93.5 | -90.4 | 16.5 | 25.16 | 28.76 |
| Net income 1 | 111.1 | 62.5 | -80.5 | 8.87 | 15.04 | 14.69 |
| Net margin | - | 5.77% | -7.69% | 0.82% | 1.34% | 1.24% |
| EPS 2 | - | 1.260 | -1.610 | 0.1840 | 0.2960 | 0.2900 |
| Free Cash Flow 1 | - | 73 | 44.9 | 38.95 | 45.72 | - |
| FCF margin | - | 6.74% | 4.29% | 3.62% | 4.07% | - |
| FCF Conversion (EBITDA) | - | 45.83% | 46% | 38.22% | 42.43% | - |
| FCF Conversion (Net income) | - | 116.8% | - | 439.08% | 303.97% | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 4/4/22 | 2/15/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 268 | 265.7 | 275.1 | 265.1 | 262.3 | 258.3 | 260.6 | 262.4 | 267.2 | 271.5 | 274.4 | 276.1 | 277 |
| EBITDA 1 | 40.3 | 31.7 | 40.3 | 25.3 | 23.9 | 23.2 | 25.2 | 25.3 | 24.54 | 25.24 | 26.74 | 25.87 | 26.66 |
| EBIT 1 | 32.1 | 23.7 | 27 | 14.2 | 16.2 | 15.5 | 17.5 | 12.9 | 15.75 | 16.71 | 18.6 | 17.07 | 18.91 |
| Operating Margin | 11.98% | 8.92% | 9.81% | 5.36% | 6.18% | 6% | 6.72% | 4.92% | 5.9% | 6.15% | 6.78% | 6.18% | 6.83% |
| Earnings before Tax (EBT) 1 | - | 11.7 | 19.2 | 4.2 | -84.7 | -3 | -7.4 | 1.1 | 2.916 | 4.806 | 6.94 | 4.121 | 5.301 |
| Net income 1 | 20.34 | 8.6 | 7.7 | 2.7 | -74.4 | -2.4 | -6.4 | 0.2 | 1.923 | 2.848 | 4.375 | 2.783 | 2.062 |
| Net margin | 7.59% | 3.24% | 2.8% | 1.02% | -28.36% | -0.93% | -2.46% | 0.08% | 0.72% | 1.05% | 1.59% | 1.01% | 0.74% |
| EPS 2 | 0.4100 | 0.1700 | 0.1500 | 0.0500 | -1.490 | -0.0500 | -0.1300 | 0.0100 | 0.0340 | 0.0540 | 0.0920 | 0.0550 | 0.0400 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/1/22 | 11/1/22 | 2/15/23 | 5/9/23 | 8/9/23 | 11/7/23 | 3/6/24 | 5/8/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 560 | 525 | 517 | 492 | 488 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.517 x | 5.381 x | 5.07 x | 4.57 x | 4.186 x |
| Free Cash Flow 1 | - | 73 | 44.9 | 38.9 | 45.7 | - |
| ROE (net income / shareholders' equity) | - | 6.55% | 1.59% | 2.05% | 3.09% | 3.54% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 17.00 | 13.40 | 13.60 | 14.00 | 14.50 |
| Cash Flow per Share 2 | - | 1.610 | 0.9700 | 1.000 | 1.150 | - |
| Capex 1 | - | 7.1 | 3.5 | 7.11 | 7.59 | 8.35 |
| Capex / Sales | - | 0.66% | 0.33% | 0.66% | 0.68% | 0.71% |
| Announcement Date | 4/4/22 | 2/15/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.72
USD
Average target price
9.179
USD
Spread / Average Target
+5.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.75% | 443M | |
| +2.28% | 3.18B | |
| 0.00% | 1.89B | |
| +71.26% | 710M | |
| -49.19% | 300M | |
| -27.09% | 163M | |
| -13.64% | 133M | |
| +5.77% | 67.86M |
- Stock Market
- Equities
- EHAB Stock
- Financials Enhabit, Inc.
